Being a small but highly innovative company, operating in the borderland between science and business, Enza Biotech sets out to become a key player in the transition from a fossil-dependent to a biobased society. Enza Biotech was founded in 2012 and became part of the Croda International group in 2017. The company is situated in Lund, in Southern Sweden, close to the scientific community at Lund University and the innovative environment at Ideon Science Park.

By combining insights in industrial challenges with a molecular understanding and knowledge in biotechnology-based production methods, novel and innovative molecules can be designed and produced with benefits that meet the needs in the market.

Enza Biotech takes responsibility for our future and contributes to the development of sustainable and “green” products made from biobased raw materials.

The modus operandi of Enza Biotech is based on the identification of a need for molecular performance and based on structure-performance studies, molecules responding to the need are designed. A synthetic route based on enzymatic catalysis is developed and finally the beneficial properties of the synthesized molecules are verified. Thereafter Enza Biotech adapts the process to industrially relevant conditions and brings the technology to market.

modus_operandi

Oligomeric alkyl glycosides, OLMAG surfactants, are Enza Biotech’s first line of green molecules with both functional and toxicological advantages. They will give formulators a new and beneficial alternative to existing nonionic surfactants.